Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Structure of AZD3582. | Download Scientific Diagram
Azd8205 – Application in Therapy and Current Clinical Research
Structure of topoisomerase I inhibitors-based ADCs. A FDA-approved ADCs ...
Study of AZD8205 Alone or with Other Cancer Drugs for Patients with ...
Azd8205 – Aplicación en terapia e investigaciones clínicas actuales
AZD8205 Phase I/IIa Trial Result | ESMO 2024 | DelveInsight Business ...
AZD8205 for Endometrial Cancer Clinical Trial 2025 | Power
AZD8205 for Breast Cancer Clinical Trial 2023 | Power
Novel ADC AZD8205 demonstrates manageable safety profile and ...
Molecular structure of AZD1305. | Download Scientific Diagram
ESMO: Novel ADC AZD8205 demonstrates manageable safety profile and ...
ESMO 2024: Novel ADC AZD8205 demonstrates manageable safety profile and ...
| Crystal structure of the S glycoprotein RBD in complex with both Fab ...
Badanie nad AZD8205 w leczeniu zaawansowanych lub przerzutowych ...
2 The chemical structure of radiolabelled AZD1152-HQPA. | Download ...
ESMO: Novel ADC AZD8205 Demonstrates Manageable Sa | Newswise
Chemical structure of AZD3965. | Download Scientific Diagram
Chemical structure of AZD7325 | Download Scientific Diagram
Structure of AZD2563. | Download Scientific Diagram
Emerging ADC Targets: B7-H3 and B7-H4
Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 ...
阿斯利康 B7-H4 ADC 国内临床即将启动！中国研发提速中_药物_Enhertu_研究
阿斯利康AZD批准8205临床试验申请-试药员招聘与临床试验信息平台
有效载荷（payload）的多样性：ADC药物未来开发的关键一环 - 脉脉
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody ...
AZD8205（B7-H4 ADC）联合AZD5305的临床前研究 - 平头哥
2024年ESMO：抗体偶联药AZD8205 的首次人体临床试验数据公布，多个肿瘤类型迎来新希望！-MedSci.cn
Computational Study on New Natural Compound Inhibitors of Pyruvate ...
Puxitatug samrotecan drug-linker (AZD8205 drug-linker) | Drug-Linker ...
AZD-8205(AZD-8205) - 药物靶点：B7-H4 x Top I_在研适应症：恶性实体肿瘤，转移性子宫内膜恶性肿瘤，腺样囊性癌 ...
puxitatug samrotecan (AZD8205) / AstraZeneca
Adenosine triphosphate-competitive mTOR inhibition suppresses T cell ...
【AACR 2023】ADC药物”角力”AACR - 企业动态 - 丁香通
Datroway (Datopotamab Deruxtecan-dlnk for Injection): Side Effects ...
AZD8205-hIgG1 - Kyinno Bio
Puxitatug samrotecan (AZD 8205) | ADCs | MedChemExpress
Distinct Structural Mechanisms for Inhibition of Pyruvate Dehydrogenase ...
AZD-8205(AZD-8205) - 药物靶点：B7-H4 x Top I_在研适应症：子宫内膜癌，恶性实体肿瘤，转移性子宫内膜恶性肿瘤 ...
阿斯利康：自研 B7-H4 ADC 国内启动临床_Insight_药物_包括
PK/PD/efficacy relationship of AZD5305 in a BRCA1m TNBC xenograft tumor ...
B7-H4 ADC AZD8205，首次披露临床结果_Insight_患者_治疗
AZD-8205(AZD-8205) - 药物靶点：B7-H4 x Top I_在研适应症：恶性实体肿瘤，转移性子宫内膜恶性肿瘤，晚期恶性实体 ...
AZD8055 | mTOR Pathway Inhibitor | STEMCELL Technologies
AZD8421 | CDK inhibitor | CAS 3047321-53-6 | Selleck
Anti-B7-H4(AZD-8205 biosimilar) mAb-B7-H4 Biosimilar mAb for ELISA-DIMA ...
Small-molecule Articles | Smolecule
Safety and preliminary efficacy of puxitatug samrotecan (AZD8205) in ...
mTOR抑制剂(AZD8055)
Antibody-drug Conjugate Information | ADCdb
Introduction to ADC Drug Payloads – AntBio
606O Initial results from a first-in-human study of the B7-H4-directed ...
Chemical structures of AZD1775 and PD0166285. Chemical structures of ...
Structure, biochemical, and cellular activity of AZD2014. A, chemical ...
Schematic of AZD0466 drug substance and drug product process. A ...
Abstract 1765: Discovery and first disclosure of AZD8205, a B7-H4 ...
靶向B7-H4，新型ADC药物AZD8205 在HR+/HER2–晚期乳腺癌临床研究中显疗效 - MedFind
子宫内膜癌新药临床试验：ADC药物Puxitatug Samrotecan（AZD8205）-印塔健康官网
Small molecules shield mice against hearing loss
Clinical PARP inhibitors allosterically induce PARP2 retention on DNA ...
ISSX 2022 - Hypha Discovery
Overlay of substructure of RBD/AZD8895 in RBD/AZD8895/AZD1061 complex ...
How does AstraZeneca's PARP inhibitor differentiate?
B7家族的泛癌种新星：B7-H4 - 知乎
AZD-1305 | Antiarrhythmic Agent | MedChemExpress
2024年ESMO：抗体偶联药AZD8205 的首次人体临床试验数据公布，多个肿瘤类型迎来新希望！_腾讯新闻
Structures and atom numbering of the studied compounds, and the ...
AZD-8205(AZD-8205) - 药物靶点：B7-H4 x Top I_在研适应症：晚期恶性实体瘤，胆管癌，胆道癌_专利_临床_研发
Anti-B7-H4 (AZD-8205 biosimilar) mAb (HDBS0172) - Assay Genie
Schematic representation of the AZD2 molecular structure. | Download ...
AZD0516 | Anti-STEAP2 ADC | MedChemExpress
AZD-5462 | Selleck Chemicals
AZD8055 is an ATP-competitive mTOR kinase inhibitor. A, chemical ...
2024年ESMO：抗体偶联药AZD8205 的首次人体临床试验数据公布，多个肿瘤类型迎来新希望！医药新闻-ByDrug-一站式医药资源共享 ...
AZD8055 Exerts Antitumor Effects on Colon Cancer Cells by Inhibiting ...
The Use of Heterocyclic Azo Dyes on Different Textile Materials: A Review
AZD-8835 | PI3Kα/δ Inhibitor | MedChemExpress
席卷全球，ADC研发进展 - 药时代DrugTimes
AZD6482 | PI3K inhibitor | CAS 1173900-33-8 | Selleck
AZD-PEG2-PFP | Biochemical Assay Reagent | MedChemExpress
中美合作！抗癌新藥AZD8205有效治療癌症得到證實！ - 每日頭條
Research Progress of Liquid Crystal Molecules for Application in ...
